Suppr超能文献

单克隆抗体诱导的移植耐受

Transplantation tolerance with monoclonal antibodies.

作者信息

Wood K J

机构信息

Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, UK.

出版信息

Semin Immunol. 1990 Nov;2(6):389-99.

PMID:2104277
Abstract

Monoclonal antibodies (Mabs) are powerful tools for manipulating the immune system as they are capable of triggering, amplifying or suppressing immune responses. The resultant effect of monoclonal antibody (MAb) manipulation is related not only to the antigenic specificity of the antibody used, but also to its structural properties and mechanism of action. There has been much interest in using MAbs to control or regulate immune responses in vivo and they are now commonly used successfully in clinical transplantation for the treatment of graft rejection. The induction of transplantation tolerance in adult recipients is an important goal of transplantation research. The development of MAbs for immunotherapy has allowed new approaches for the induction of tolerance to vascularised organ grafts to be explored.

摘要

单克隆抗体(Mabs)是操纵免疫系统的有力工具,因为它们能够触发、放大或抑制免疫反应。单克隆抗体(MAb)操纵的最终效果不仅与所用抗体的抗原特异性有关,还与其结构特性和作用机制有关。人们对使用单克隆抗体在体内控制或调节免疫反应很感兴趣,它们现在已成功地广泛用于临床移植以治疗移植排斥反应。诱导成年受者的移植耐受是移植研究的一个重要目标。用于免疫治疗的单克隆抗体的开发使得探索诱导对血管化器官移植耐受的新方法成为可能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验